Skip to content

Zero-fluoroscopy Approach Versus Fluoroscopic Approach for the Ablation of Paroxysmal Supraventricular Tachycardia

Multi-center, Controlled Trial to Compare the Feasibility, Safety and Efficacy of Zero-fluoroscopic Approach With Fluoroscopic Approach for the Ablation of Paroxysmal Supraventricular Tachycardia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03042078
Acronym
ZFA-PSVT
Enrollment
3060
Registered
2017-02-03
Start date
2012-01-31
Completion date
2018-12-31
Last updated
2023-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paroxysmal Supraventricular Tachycardia

Keywords

Fluoroscopy, Ablation, Three dimensional, Paroxysmal supraventricular tachycardia, Radiation

Brief summary

This study is aimed to compare the feasibility, safety and efficacy of a zero-fluoroscopic approach using Ensite NavX with conventional fluoroscopic approach using Ensite NavX plus fluoroscopy for the ablation of paroxysmal supraventricular tachycardia.

Detailed description

Fluoroscopy is the imagine modality routinely used in catheter ablation of cardiac arrhythmias. As we all know,fluoroscopic radiation is harmful both to the patients and the operation staffs. Recently,three-dimensional navigation systems have been developed and implemented in electrophysiological procedures for guiding catheters inside the heart chambers. Among the three-dimensional navigation systems, Ensite NavX is a promising system used for zero-fluoroscopic approach for performing catheter ablation of paroxysmal supraventricular tachycardia. This study is aimed to compare the feasibility, safety and efficacy of a zero-fluoroscopic approach using Ensite NavX with conventional fluoroscopic approach using Ensite NavX plus fluoroscopy for the ablation of paroxysmal supraventricular tachycardia.

Interventions

DEVICEZero-fluoroscopic ablation

Catheter ablation will be performed under the guidance of Ensite NavX and without the use of fluoroscopy.

DEVICEConventional fluoroscopic ablation

Catheter ablation will be performed under the guidance of Ensite NavX plus fluoroscopy.

Sponsors

Chinese Academy of Medical Sciences, Fuwai Hospital
CollaboratorOTHER
First Affiliated Hospital, Sun Yat-Sen University
CollaboratorOTHER
Xiangyang Central Hospital
CollaboratorOTHER
First Affiliated Hospital of Guangxi Medical University
CollaboratorOTHER
Guangdong Provincial People's Hospital
CollaboratorOTHER
Morristown Memorial Hospital
CollaboratorOTHER
Beijing Anzhen Hospital
CollaboratorOTHER
Ningbo No. 1 Hospital
CollaboratorOTHER
Tongji Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
12 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Atrioventricular Nodal Reentrant Tachycardia * Atrioventricular Reentrant Tachycardia

Exclusion criteria

* Atrial Tachycardia * Organic supraventricular tachycardia

Design outcomes

Primary

MeasureTime frameDescription
Procedural success rateone yearProcedural success for AVNRT was defined as the absence of inducible tachycardia either under basal condition or under isoproterenol stimulation. Procedural success for AVRT was defined as the non-inducibility of tachycardia, loss of pre-excitation (if manifest), loss of retrograde accessory pathway conduction and transient atrioventricular block induced by intravenous adenosine.

Secondary

MeasureTime frameDescription
Complicationsone yearComplications were defined as pseudoaneurysm, arterialvenous fistula, pneumothorax, second- or third-degree atrioventricular block, cardiac tamponade, or other serious complications requiring intervention.
Immediate success rateone dayProcedural success for AVNRT was defined as the absence of inducible tachycardia either under basal condition or under isoproterenol stimulation. Procedural success for AVRT was defined as the non-inducibility of tachycardia, loss of pre-excitation (if manifest), loss of retrograde accessory pathway conduction and transient atrioventricular block induced by intravenous adenosine.
Recurrence Rate1 year2\. An ECG and electrophysiology study would be performed to rule out recurrence when the patients had suspicious symptoms or signs.
Total procedure timeone dayProcedure time (in minutes) was defined as the interval from the beginning of local anesthesia to extraction of all femoral venous sheaths at the end of the procedure. Total ablation time was calculated in seconds but time for tentative ablation was not taken into account.
Fluoroscopy timeone day2\. Fluoroscopy time (in minutes) was defined as thetotal duration of exposure during the procedure.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026